EATG » Projects » EFOEUPATI – Ensuring the future of EUPATI beyond 2020

EFOEUPATI – Ensuring the future of EUPATI beyond 2020

Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for these to work, building on those already established under IMI-EUPATI.

Project leader: European Patients Forum (EPF)

Main partners: Irish Platform for Patiens’ Organisations Science and Industry Limited by Guarantee (IPPOSI), EATG, European Forum for Good Clinical Practice (EFGCP), Kobenhavns Universitet (UCPH), AbbVie, Bayer, GSK, Novo Nordisk, Novartis, Pfizer, UCB

EATG participation: Project partner (in WP1, WP2 and WP3)

Duration: 2 years (started September 2018)

Main funding source/programme: Innovative Medicines Initiative (IMI)

Budget: approximately 39,000 EUR (budget amendment ongoing as of March 2019)


EATG contact person(s): Maria Dutarte (Office) at